Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Cosmos Health (COSM) Profit After Tax (2016 - 2025)

Cosmos Health's Profit After Tax history spans 13 years, with the latest figure at -$10.1 million for Q4 2025.

  • Quarterly results put Profit After Tax at -$10.1 million for Q4 2025, down 203.04% from a year ago — trailing twelve months through Dec 2025 was -$19.1 million (down 91.68% YoY), and the annual figure for FY2025 was -$19.1 million, down 18.3%.
  • Profit After Tax for Q4 2025 was -$10.1 million at Cosmos Health, down from -$5.4 million in the prior quarter.
  • In the past five years, Profit After Tax ranged from a high of $203347.0 in Q1 2022 to a low of -$10.8 million in Q4 2022.
  • The 5-year median for Profit After Tax is -$2.1 million (2021), against an average of -$2.8 million.
  • Peak annual rise in Profit After Tax hit 109.35% in 2022, while the deepest fall reached 634.96% in 2022.
  • Year by year, Profit After Tax stood at -$1.5 million in 2021, then crashed by 634.96% to -$10.8 million in 2022, then surged by 88.61% to -$1.2 million in 2023, then crashed by 171.6% to -$3.3 million in 2024, then plummeted by 203.04% to -$10.1 million in 2025.
  • According to Business Quant data, Profit After Tax over the past three periods came in at -$10.1 million, -$5.4 million, and -$2.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.